GAMA
NARI

Graticule Asia Macro Advisors’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Graticule Asia Macro Advisors’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8,000
Closed -$698K – 224
2020
Q4 		$698K Hold
8,000
– – 0.33% 53
2020
Q3 		$552K Buy
+8,000
New +$514K 0.05% 59

Other funds holding NARI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Graticule Asia Macro Advisors's NARI Position: Q1 2021 in Review

Graticule Asia Macro Advisors sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2021, closing a stake of 8,000 shares — an estimated $698K sold.

Graticule Asia Macro Advisors first reported a position in NARI in Q3 2020 and held it in 2 quarters. The position peaked at $698K in Q4 2020. 185 funds tracked by Wall St. Rank hold NARI as of Q1 2021.

  • Graticule Asia Macro Advisors reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Graticule Asia Macro Advisors sold 8,000 Inari Medical, Inc. Common Stock shares in Q1 2021, an estimated $698K.
  • Graticule Asia Macro Advisors first reported a position in Inari Medical, Inc. Common Stock in Q3 2020 and held it in 2 quarters.
  • Graticule Asia Macro Advisors's Inari Medical, Inc. Common Stock position peaked at $698K in Q4 2020.
  • 185 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2021.

Based on Graticule Asia Macro Advisors's 13F filing for Q1 2021, filed 17 May 2021.